Potentiation of the Antitumor Effect of Merocyanine 540‐mediated Photodynamic Therapy by Amifostine and Amphotericin B
- 1 March 2006
- journal article
- research article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 82 (2), 458-465
- https://doi.org/10.1562/2005-09-02-ra-672
Abstract
Leukemia and lymphoma cells are much more sensitive to Merocyanine 540 (MC540)–mediated photodynamic therapy (PDT) than normal pluripotent hematopoietic stem cells and normal colony forming unit–granulocyte/macrophage progenitors (CFU-GM). By contrast, most solid tumor cells are only moderately sensitive to MC540-PDT. The limited activity against solid tumor cells has detracted from MC540's appeal as a broad-spectrum purging agent. We report here that noncytotoxic concentrations of amifostine (Ethyol, Ethiofos, WR-2721) and amphotericin B used either alone or in combination potentiate the MC540-sensitized photoinactivation of leukemia cells, wild-type small cell lung cancer cells and cisplatin-resistant small cell lung cancer cells. Amphotericin B also enhances the MC540-sensitized photoinactivation of normal CFU-GM, whereas amifostine protects CFU-GM against the cytotoxic action of MC540-PDT. The yield of CD34-positive normal hematopoietic stem and progenitor cells is only minimally diminished by pretreatment with amifostine, amphotericin B or combinations of amifostine plus amphotericin B. Purging protocols that combine MC540-PDT with amifostine or with amifostine plus amphotericin B could offer a simple and effective approach to the purging of autologous stem cell grafts that are contaminated with solid tumor cells or the purging of stem cell grafts from heavily pretreated leukemia patients that contain reduced numbers of normal stem and progenitor cells and, therefore, can ill afford additional losses caused by purging.This publication has 72 references indexed in Scilit:
- Effect of Membrane Potential on the Binding of Merocyanine 540 to Human ErythrocytesPhotochemistry and Photobiology, 1998
- Photochemical purging of autologous bone marrow grafts: assessment of damage to stem cells and the microenvironment in long-term marrow culturesBone Marrow Transplantation, 1997
- AmifostineDrugs, 1995
- POTENTIATION OF MEROCYANINE 540-MEDIATED PHOTODYNAMIC THERAPY BY SALICYLATE and RELATED DRUGSPhotochemistry and Photobiology, 1995
- Involvement of the polyamine transport system in cellular uptake of the radioprotectants WR-1065 and WR-33278Carcinogenesis: Integrative Cancer Research, 1995
- The role of serum and serum components in the merocyanine 540-sensitized photoinactivation of K562 leukemia cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 1992
- MODULATION BY THIOLS OF THE MEROCYANINE 540‐SENSITIZED PHOTOLYSIS OF LEUKEMIA CELLS, RED CELLS, AND Herpes simplex VIRUS TYPE 1Photochemistry and Photobiology, 1991
- Reversal of cancer chemotherapeutic resistance by amphotericin B—A broad phase I–II pilot studyEuropean Journal of Cancer and Clinical Oncology, 1987
- Absorption and emission characteristics of merocyanine 540 in microemulsionsJournal of the American Chemical Society, 1983
- Spectroscopic evidence for interactions of merocyanine 540 with valinomycin in the presence of potassiumFEBS Letters, 1980